Poietics human osteoclast precursors

Friday, 04 February, 2011 | Supplied by: Capsugel Australia Pty Ltd

Osteoclasts are large, multinucleated cells that play an active role in bone resorption. The Poietics human osteoclast precursor cell system is designed for use in high-throughput research applications in osteoporosis, bone resorption and other bone-related diseases.

Poietics osteoclast precursors are supplied cryopreserved with >1 million cells per amp. Yield ≥70% conversion to mature and functional osteoclasts when differentiated using Poietics media.

Online: www.capsugel.com
Phone: 1300 657508
Related Products

GeneTex circadian rhythm antibodies

Circadian rhythms are physical, behavioural and mental changes that respond primarily to the...

Enzo Life Sciences SCREEN-WELL Cardiotoxicity Library

The SCREEN-WELL Cardiotoxicity Library from Enzo Life Sciences is a focused collection of 130...

HUABIO Cytokeratin 4 Recombinant Rabbit Monoclonal Antibody

Cytokeratin 4 is expressed in the suprabasal layer of the stratified epithelium of the...

Content from other channels on our network

Bakery saves costs by converting to Gates' belt technology

Researchers help onion producers reduce Salmonella risks

New framework for steviol glycosides

WA avocados set to be a smash in Japan

Designing compostable health food packaging

2022 Thought Leaders: Boris Gabin

Modern manufacturing: more than a buzzword

Thales Australia to expand advanced manufacturing in Lithgow

New release of ABB Ability Sugar Library to boost flexibility

Australia's largest rocket engine test a success

[SC] Demystifying Portable Air Purifiers in Healthcare

Polypharmacy management

Two antiviral COVID-19 treatments approved

Rural care — where to now?

Eliminate the silos that inhibit evidence-based practice improvements

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd